Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$31.15 - $33.39 $93 - $100
-3 Reduced 25.0%
9 $0
Q3 2022

Nov 14, 2022

SELL
$30.9 - $33.55 $432 - $469
-14 Reduced 53.85%
12 $0
Q2 2022

Aug 10, 2022

SELL
$23.75 - $31.69 $142 - $190
-6 Reduced 18.75%
26 $1,000
Q1 2022

May 13, 2022

SELL
$19.97 - $26.94 $1,877 - $2,532
-94 Reduced 74.6%
32 $1,000
Q4 2021

Feb 10, 2022

BUY
$17.46 - $21.61 $2,199 - $2,722
126 New
126 $3,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.